976 filings
Page 3 of 49
8-K
SEEL
Seelos Therapeutics Inc
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
12:07pm
8-K
SEEL
Seelos Therapeutics Inc
24 Nov 23
Seelos Therapeutics Announces 1-for-30 Reverse Stock Split
11:10am
10-Q
2023 Q3
SEEL
Seelos Therapeutics Inc
Quarterly report
14 Nov 23
4:06pm
8-K
SEEL
Seelos Therapeutics Inc
3 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:15pm
8-K
SEEL
Seelos Therapeutics Inc
2 Oct 23
Entry into a Material Definitive Agreement
6:03am
EFFECT
SEEL
Seelos Therapeutics Inc
2 Oct 23
Notice of effectiveness
12:15am
424B3
SEEL
Seelos Therapeutics Inc
29 Sep 23
Prospectus supplement
4:56pm
CORRESP
SEEL
Seelos Therapeutics Inc
26 Sep 23
Correspondence with SEC
12:00am
8-K
SEEL
Seelos Therapeutics Inc
25 Sep 23
Entry into a Material Definitive Agreement
4:06pm
424B5
SEEL
Seelos Therapeutics Inc
25 Sep 23
Prospectus supplement for primary offering
6:02am
8-K
SEEL
Seelos Therapeutics Inc
20 Sep 23
Seelos Therapeutics Announces Top Line Results from SLS-002 Phase II Study in Adults with Major Depressive Disorder at Imminent Risk of Suicide
7:00am
UPLOAD
SEEL
Seelos Therapeutics Inc
20 Sep 23
Letter from SEC
12:00am
S-3
SEEL
Seelos Therapeutics Inc
Shelf registration
15 Sep 23
4:01pm
8-K
SEEL
Seelos Therapeutics Inc
14 Sep 23
Other Events
9:00am
4
Michael Joseph Golembiewski
1 Sep 23
SEELOS THERAPEUTICS / Michael Joseph Golembiewski ownership change
4:15pm
10-Q
2023 Q2
SEEL
Seelos Therapeutics Inc
Quarterly report
11 Aug 23
4:05pm
8-K
SEEL
Seelos Therapeutics Inc
29 Jun 23
Other Events
9:00am
8-K
SEEL
Seelos Therapeutics Inc
26 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:05pm
8-K
SEEL
Seelos Therapeutics Inc
19 May 23
Entry into a Material Definitive Agreement
5:00pm
10-Q
2023 Q1
SEEL
Seelos Therapeutics Inc
Quarterly report
12 May 23
4:05pm